{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:38:05Z","timestamp":1792442285910,"version":"4.5.0"},"reference-count":124,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Paediatric Respiratory Reviews"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.prrv.2026.02.002","type":"journal-article","created":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T22:55:20Z","timestamp":1770591320000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatable traits in children with bronchiectasis"],"prefix":"10.1016","author":[{"given":"Jos\u00e9phine","family":"Annereau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apolline","family":"Gonsard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rola Abou","family":"Taam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Delacourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Sermet-Gaudelus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Hadchouel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7324-4992","authenticated-orcid":false,"given":"David","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prrv.2026.02.002_b0005","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S0140-6736(18)31554-X","article-title":"Bronchiectasis in children: diagnosis and treatment","volume":"392","author":"Chang","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.prrv.2026.02.002_b0010","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1186\/s12913-019-4414-5","article-title":"Health-resource use and quality of life in children with bronchiectasis: a multi-center pilot cohort study","volume":"19","author":"Lovie-Toon","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.prrv.2026.02.002_b0015","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.3390\/jcm10245856","article-title":"Burden of Care for Children with Bronchiectasis from Parents\/Carers Perspective","volume":"10","author":"Marchant","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0020","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/resp.13828","article-title":"Cost of hospitalization for bronchiectasis exacerbation in children","volume":"25","author":"Goyal","year":"2020","journal-title":"Respirology"},{"key":"10.1016\/j.prrv.2026.02.002_b0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3389\/fped.2017.00027","article-title":"The Epidemiology of Chronic Suppurative Lung Disease and Bronchiectasis in Children and Adolescents","volume":"5","author":"McCallum","year":"2017","journal-title":"Front Pediatr"},{"key":"10.1016\/j.prrv.2026.02.002_b0030","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00264-2022","article-title":"International consensus statement on quality standards for managing children\/adolescents with bronchiectasis from the ERS CRC Child-BEAR-Net","volume":"59","author":"Chang","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.02.002_b0035","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02990-2020","article-title":"European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis","volume":"58","author":"Chang","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.02.002_b0040","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: toward precision medicine of chronic airway diseases","volume":"47","author":"Agusti","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.02.002_b0045","article-title":"The Asthma-COPD Overlap Syndrome: a Common Clinical Problem in the elderly","volume":"2011","author":"Zeki","year":"2011","journal-title":"J Allergy (Cairo)"},{"key":"10.1016\/j.prrv.2026.02.002_b0050","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02058-2018","article-title":"Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits down under International Workshop report","volume":"53","author":"McDonald","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.02.002_b0055","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/resp.14325","article-title":"Treatable traits in the NOVELTY study","volume":"27","author":"Agust\u00ed","year":"2022","journal-title":"Respirology"},{"key":"10.1016\/j.prrv.2026.02.002_b0060","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/resp.14644","article-title":"Treatable traits models of care","volume":"29","author":"McDonald","year":"2024","journal-title":"Respirology"},{"key":"10.1016\/j.prrv.2026.02.002_b0065","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01269-2018","article-title":"Treatable traits in bronchiectasis","volume":"52","author":"Boaventura","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.02.002_b0070","volume":"17","author":"Pembridge","year":"2021","journal-title":"Precision medicine in bronchiectasis Breathe (Sheff)"},{"key":"10.1016\/j.prrv.2026.02.002_b0075","doi-asserted-by":"crossref","first-page":"00934","DOI":"10.1183\/23120541.00934-2020","article-title":"Treatable traits in an English cohort: prevalence and predictors of future decline in lung function and quality of life in COPD","volume":"7","author":"Sarwar","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.prrv.2026.02.002_b0080","doi-asserted-by":"crossref","DOI":"10.1177\/17534666251335774","article-title":"Treatable traits in interstitial lung disease: a narrative review","volume":"19","author":"Harrison","year":"2025","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.prrv.2026.02.002_b0085","article-title":"Treatable traits: a comprehensive precision medicine approach in interstitial lung disease","volume":"62","author":"Khor","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.02.002_b0090","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaip.2024.01.020","article-title":"Treatable Traits in Asthma: the Importance of Extrapulmonary Traits-GERD, CRSwNP, Atopic Dermatitis, and Depression\/Anxiety","volume":"12","author":"McDonald","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.prrv.2026.02.002_b0095","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-063064","article-title":"Primary Ciliary Dyskinesia","volume":"153","author":"Wee","year":"2024","journal-title":"Pediatrics"},{"key":"10.1016\/j.prrv.2026.02.002_b0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S2213-2600(23)00226-6","article-title":"Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD): a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial","volume":"12","author":"Ringshausen","year":"2024","journal-title":"Lancet Respir Med"},{"issue":"Suppl 1","key":"10.1016\/j.prrv.2026.02.002_b0105","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.tmrv.2009.09.011","article-title":"The use of immunoglobulin therapy for patients with primary immune deficiency: an evidence-based practice guideline","volume":"24","author":"Shehata","year":"2010","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.prrv.2026.02.002_b0110","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fped.2019.00295","article-title":"Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives","volume":"7","author":"Castagnoli","year":"2019","journal-title":"Front Pediatr"},{"key":"10.1016\/j.prrv.2026.02.002_b0115","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/ppul.21587","article-title":"Bronchiectasis in chronic pulmonary aspiration: risk factors and clinical implications","volume":"47","author":"Piccione","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2026.02.002_b0120","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1183\/09031936.06.00138305","article-title":"Advances in the diagnosis and management of chronic pulmonary aspiration in children","volume":"28","author":"Boesch","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.02.002_b0125","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12887-014-0299-y","article-title":"The etiologies of non-CF bronchiectasis in childhood: a systematic review of 989 subjects","volume":"14","author":"Brower","year":"2014","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.prrv.2026.02.002_b0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1177\/021849230501300102","article-title":"Surgical repair of double aortic arch: 16-year experience","volume":"13","author":"Shanmugam","year":"2005","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1016\/j.prrv.2026.02.002_b0135","article-title":"ERS statement on tracheomalacia and bronchomalacia in children","volume":"54","author":"Wallis","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.02.002_b0140","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1002\/ppul.27068","article-title":"Innovations in the care of childhood interstitial lung disease associated with connective tissue disease and immune-mediated disorders","volume":"59","author":"Samad","year":"2024","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2026.02.002_b0145","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/039463200702000422","article-title":"Effects of a program of hospital-supervised chest physical therapy on lung function tests in children with chronic respiratory disease: 1-year follow-up","volume":"20","author":"Indinnimeo","year":"2007","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.prrv.2026.02.002_b0150","doi-asserted-by":"crossref","unstructured":"Lee AL, Burge AT, Holland AE. Airway clearance techniques for bronchiectasis. Cochrane Database Syst Rev 2015;2015:CD008351. https:\/\/doi.org\/10.1002\/14651858.CD008351.pub3.","DOI":"10.1002\/14651858.CD008351.pub3"},{"key":"10.1016\/j.prrv.2026.02.002_b0155","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01926-2017","article-title":"Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial","volume":"51","author":"Mu\u00f1oz","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.02.002_b0160","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/ppul.25206","article-title":"Effectiveness of hypertonic saline nebulization in airway clearance in children with non-cystic fibrosis bronchiectasis: a randomized control trial","volume":"56","author":"Anuradha","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2026.02.002_b0165","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJMoa2510095","article-title":"Hypertonic Saline or Carbocisteine in Bronchiectasis","volume":"393","author":"Bradley","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0170","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.pupt.2009.06.002","article-title":"Alternative mechanisms for tiotropium","volume":"22","author":"Bateman","year":"2009","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.prrv.2026.02.002_b0175","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02184-2021","article-title":"Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial","volume":"59","author":"Jayaram","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.02.002_b0180","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S2213-2600(19)30254-1","article-title":"Efficacy of oral amoxicillin-clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial","volume":"7","author":"Goyal","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0185","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(18)31723-9","article-title":"Amoxicillin-clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial","volume":"392","author":"Goyal","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.prrv.2026.02.002_b0190","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S2213-2600(13)70185-1","article-title":"Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis intervention Study): a multicentre, double-blind, randomised controlled trial","volume":"1","author":"Valery","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0195","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S2213-2600(20)30058-8","article-title":"Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial","volume":"8","author":"Kobbernagel","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0200","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01953-2017","article-title":"The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis","volume":"51","author":"Ara\u00fajo","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.02.002_b0205","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12887-020-02062-4","article-title":"Exacerbations and Pseudomonas aeruginosa colonization are associated with altered lung structure and function in primary ciliary dyskinesia","volume":"20","author":"Piatti","year":"2020","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.prrv.2026.02.002_b0210","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1128\/JCM.02164-13","article-title":"Complexity, temporal stability, and clinical correlates of airway bacterial community composition in primary ciliary dyskinesia","volume":"51","author":"Rogers","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.prrv.2026.02.002_b0215","doi-asserted-by":"crossref","first-page":"00253","DOI":"10.1183\/23120541.00253-2024","article-title":"Associations between respiratory pathogens and lung function in primary ciliary dyskinesia: cross-sectional analysis from the PROVALF-PCD cohort","volume":"10","author":"Rubbo","year":"2024","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.prrv.2026.02.002_b0220","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1513\/AnnalsATS.202210-858OC","article-title":"Efficacy of Antibiotic Eradication Therapy of Early Pseudomonas aeruginosa Infection in Children with Primary Ciliary Dyskinesia","volume":"20","author":"Gatt","year":"2023","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.prrv.2026.02.002_b0225","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S2213-2600(24)00225-X","article-title":"Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months","volume":"12","author":"Haworth","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0230","doi-asserted-by":"crossref","first-page":"00938","DOI":"10.1183\/23120541.00938-2023","article-title":"A phase 4 multicentre, 2\u00d72 factorial randomised, double-blind, placebo-controlled trial to investigate the efficacy and safety of tobramycin inhalation solution for Pseudomonas aeruginosa eradication in bronchiectasis: ERASE","volume":"10","author":"Gao","year":"2024","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.prrv.2026.02.002_b0235","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.02.002_b0240","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1164\/rccm.202307-1165OC","article-title":"Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry patients","volume":"210","author":"Aksamit","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0245","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02469-2017","article-title":"Prevalence, risk factors and prognosis of nontuberculous mycobacterial infection among people with bronchiectasis: apopulation survey","volume":"51","author":"Shteinberg","year":"2018","journal-title":"Eur Respir J"},{"issue":"Suppl 1","key":"10.1016\/j.prrv.2026.02.002_b0250","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2015-207360","article-title":"US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis","volume":"71","author":"Floto","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.prrv.2026.02.002_b0255","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0179-2024","article-title":"Neutrophilic inflammation in bronchiectasis","volume":"34","author":"Chalmers","year":"2025","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.prrv.2026.02.002_b0260","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","article-title":"Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study","volume":"9","author":"Keir","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0265","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12890-023-02444-1","article-title":"The effect of azithromycin on sputum inflammatory markers in bronchiectasis","volume":"23","author":"Terpstra","year":"2023","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0270","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1056\/NEJMoa2411664","article-title":"Phase 3 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis","volume":"392","author":"Chalmers","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0275","unstructured":"Et les adolescents alors? les r\u00e9sultats d\u2019ASPEN dans cette population! \u2013 Soci\u00e9t\u00e9 de Pneumologie de Langue Fran\u00e7aise n.d. https:\/\/splf.fr\/et-les-adolescents-alors-les-resultats-daspen-dans-cette-population\/?utm_source=chatgpt.com (accessed January 31, 2026)."},{"key":"10.1016\/j.prrv.2026.02.002_b0280","article-title":"Inhaled corticosteroids for bronchiectasis","volume":"5","author":"Kapur","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.prrv.2026.02.002_b0285","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/rccm.202108-1889OC","article-title":"Characterization of Eosinophilic Bronchiectasis: a European Multicohort Study","volume":"205","author":"Shoemark","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0290","article-title":"Blood eosinophils predict inhaled fluticasone response in bronchiectasis","volume":"56","author":"Aliberti","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.02.002_b0295","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.chest.2023.04.029","article-title":"The U-Shaped Relationship between Eosinophil count and Bronchiectasis Severity: the effect of Inhaled Corticosteroids","volume":"164","author":"Mart\u00ednez-Garc\u00eda","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.prrv.2026.02.002_b0300","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/thorax-2024-221825","article-title":"Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC)","volume":"80","author":"Pollock","year":"2025","journal-title":"Thorax"},{"key":"10.1016\/j.prrv.2026.02.002_b0305","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01333-2019","article-title":"Anti-IL5 and anti-IL5R\u03b1 therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series","volume":"55","author":"Rademacher","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.02.002_b0310","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00408-024-00707-0","article-title":"Type 2 Biomarkers and their Clinical Implications in Bronchiectasis: a prospective Cohort Study","volume":"202","author":"Chen","year":"2024","journal-title":"Lung"},{"key":"10.1016\/j.prrv.2026.02.002_b0315","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1056\/NEJMoa2106567","article-title":"Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma","volume":"385","author":"Bacharier","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0320","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0325","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1164\/rccm.201807-1355OC","article-title":"Distinct \u201cImmunoallertypes\u201d of Disease and High Frequencies of Sensitization in Non-Cystic Fibrosis Bronchiectasis","volume":"199","author":"Mac Aog\u00e1in","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0330","doi-asserted-by":"crossref","unstructured":"Scadding GK, Kariyawasam HH, Scadding G, Mirakian R, Buckley RJ, Dixon T, et al. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007). Clin Exp Allergy 2017;47:856\u201389. https:\/\/doi.org\/10.1111\/cea.12953.","DOI":"10.1111\/cea.12953"},{"key":"10.1016\/j.prrv.2026.02.002_b0335","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.chest.2024.06.3843","article-title":"Aspergillus Serologic Findings and Clinical Outcomes in patients with Bronchiectasis: Data from the European Bronchiectasis Registry","volume":"167","author":"Pollock","year":"2025","journal-title":"Chest"},{"key":"10.1016\/j.prrv.2026.02.002_b0340","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/ppul.25945","article-title":"Primary ciliary dyskinesia and fungal infections: two cases of allergic bronchopulmonary aspergillosis in children","volume":"57","author":"Allaer","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2026.02.002_b0345","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1183\/09031936.04.00116004","article-title":"Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD","volume":"23","author":"O\u2019Donnell","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.02.002_b0350","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.arcped.2012.02.016","article-title":"Recommendations for pediatric oxygen therapy in acute and chronic settings: needs assessment, implementation criteria, prescription practices and follow-up","volume":"19","author":"Aubertin","year":"2012","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.prrv.2026.02.002_b0355","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1164\/rccm.201812-2276ST","article-title":"Home Oxygen Therapy for Children. an Official American Thoracic Society Clinical Practice Guideline","volume":"199","author":"Hayes","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0360","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01404-2021","article-title":"ERS statement on paediatric long-term noninvasive respiratory support","volume":"59","author":"Fauroux","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.02.002_b0365","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.healun.2019.06.022","article-title":"2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary hypertension: the European Pediatric Pulmonary Vascular Disease Network (EPPVDN), endorsed by AEPC, ESPR and ISHLT","volume":"38","author":"Hansmann","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.prrv.2026.02.002_b0370","doi-asserted-by":"crossref","first-page":"00701","DOI":"10.1183\/23120541.00701-2022","article-title":"Sinonasal disease among patients with primary ciliary dyskinesia: an international study","volume":"9","author":"Lam","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.prrv.2026.02.002_b0375","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/iid3.547","article-title":"The clinical impact of self-reported symptoms of chronic rhinosinusitis in people with bronchiectasis","volume":"10","author":"Lee","year":"2022","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.prrv.2026.02.002_b0380","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.jaip.2019.02.026","article-title":"Prevalence and Clinical Implications of Chronic Rhinosinusitis in people with Bronchiectasis: a Systematic Review","volume":"7","author":"Handley","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.prrv.2026.02.002_b0385","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/alr.21227","article-title":"Treatment and outcomes of chronic rhinosinusitis in children with primary ciliary dyskinesia: where is the evidence? a qualitative systematic review","volume":"3","author":"Mener","year":"2013","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.prrv.2026.02.002_b0390","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3906\/sag-1807-229","article-title":"Prevalence of atopy and allergic rhinitis in patients with adult non-cystic fibrosis bronchiectasis","volume":"49","author":"Niksarl\u0131o\u011flu","year":"2019","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.prrv.2026.02.002_b0395","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/19458924211041438","article-title":"Effect of medical therapy in allergic rhinitis: a systematic review and meta-analysis","volume":"36","author":"Zhang","year":"2022","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.prrv.2026.02.002_b0400","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.rmed.2018.06.031","article-title":"A qualitative synthesis of gastro-oesophageal reflux in bronchiectasis: current understanding and future risk","volume":"141","author":"McDonnell","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0405","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4103\/1817-1737.30354","article-title":"A review of 151 cases of pediatric noncystic fibrosis bronchiectasis in a tertiary care center","volume":"2","author":"Banjar","year":"2007","journal-title":"Ann Thorac Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0410","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4166\/kjg.2016.68.1.10","article-title":"Effect of Proton Pump Inhibitors in Bronchiectatic patients with Gastroesophageal Reflux Disease","volume":"68","author":"Ahn","year":"2016","journal-title":"Korean J Gastroenterol"},{"key":"10.1016\/j.prrv.2026.02.002_b0415","first-page":"987","article-title":"Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies","volume":"98","author":"Sontag","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.prrv.2026.02.002_b0420","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00298-2024","article-title":"Body mass index trajectories from birth to early adulthood and lung function development","volume":"65","author":"Wang","year":"2025","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.02.002_b0425","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/ppul.22710","article-title":"Sleep disordered breathing in patients with primary ciliary dyskinesia","volume":"48","author":"Oktem","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2026.02.002_b0430","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/resp.12273","article-title":"Sleep disordered breathing and airway disease in primary ciliary dyskinesia","volume":"19","author":"Santamaria","year":"2014","journal-title":"Respirology"},{"key":"10.1016\/j.prrv.2026.02.002_b0435","doi-asserted-by":"crossref","first-page":"00842","DOI":"10.1183\/23120541.00842-2024","article-title":"Sleep disordered breathing in children with primary ciliary dyskinesia","volume":"11","author":"Arigliani","year":"2025","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.prrv.2026.02.002_b0440","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1007\/s00431-019-03382-z","article-title":"Developmental and behavioral problems in preschool-aged primary ciliary dyskinesia patients","volume":"178","author":"Zengin Akkus","year":"2019","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.prrv.2026.02.002_b0445","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/ppul.24133","article-title":"Neurocognitive disorders and sleep in children with primary ciliary dyskinesia","volume":"53","author":"\u015ei\u015fmanlar Ey\u00fcbo\u011flu","year":"2018","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2026.02.002_b0450","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5029571","article-title":"Cognitive rehabilitation of adaptive behavior in children with neurodevelopmental disorders: a meta-analysis","volume":"2018","author":"Ahn","year":"2018","journal-title":"Occup Ther Int"},{"key":"10.1016\/j.prrv.2026.02.002_b0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227888","article-title":"Primary ciliary dyskinesia and psychological well-being in adolescence","volume":"15","author":"Valero-Moreno","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.prrv.2026.02.002_b0460","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.genhosppsych.2014.05.019","article-title":"The relationship between psychological symptoms, lung function and quality of life in children and adolescents with non-cystic fibrosis bronchiectasis","volume":"36","author":"Bahali","year":"2014","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.prrv.2026.02.002_b0465","doi-asserted-by":"crossref","first-page":"00274","DOI":"10.1183\/23120541.00274-2021","article-title":"Anxiety and depression in dutch patients with primary ciliary dyskinesia and their caregivers: associations with health-related quality of life","volume":"7","author":"Verkleij","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.prrv.2026.02.002_b0470","doi-asserted-by":"crossref","first-page":"00063","DOI":"10.1183\/23120541.00063-2019","article-title":"Health-related quality of life and psychological wellbeing are poor in children with bronchiectasis and their parents","volume":"5","author":"Cox","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.prrv.2026.02.002_b0475","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1378\/chest.11-0679","article-title":"The burden of disease in pediatric non-cystic fibrosis bronchiectasis","volume":"141","author":"Kapur","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.prrv.2026.02.002_b0480","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1471-2466-14-107","article-title":"Treatment adherence and health outcomes in patients with bronchiectasis","volume":"14","author":"McCullough","year":"2014","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0485","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.201312-2208OC","article-title":"Inhaled colistin in patients with bronchiectasis and chronic Pseudomonas aeruginosa infection","volume":"189","author":"Haworth","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0490","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12890-018-0772-8","article-title":"Objectively measured physical activity and sedentary behaviour in children with bronchiectasis: a cross-sectional study","volume":"19","author":"Joschtel","year":"2019","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0495","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/thorax-2022-219666","article-title":"Physical activity and body mass related to catch-up lung function growth in childhood: a population-based accelerated cohort study","volume":"79","author":"Koch","year":"2024","journal-title":"Thorax"},{"key":"10.1016\/j.prrv.2026.02.002_b0500","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/1465-9921-15-44","article-title":"The short and long term effects of exercise training in non-cystic fibrosis bronchiectasis\u2013a randomised controlled trial","volume":"15","author":"Lee","year":"2014","journal-title":"Respir Res"},{"key":"10.1016\/j.prrv.2026.02.002_b0505","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s13063-022-06256-2","article-title":"Bronchiectasis - Exercise as Therapy (BREATH): rationale and study protocol for a multi-center randomized controlled trial","volume":"23","author":"Jones","year":"2022","journal-title":"Trials"},{"key":"10.1016\/j.prrv.2026.02.002_b0510","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/archdischild-2024-327447","article-title":"Home use of short-acting beta agonists by children with asthma: a multicentre digital prospective study","volume":"110","author":"Gonsard","year":"2025","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.prrv.2026.02.002_b0515","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13885","article-title":"Short-acting \u03b22 -agonist use and asthma exacerbations in swedish children: a SABINA Junior study","volume":"33","author":"Mel\u00e9n","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.prrv.2026.02.002_b0520","doi-asserted-by":"crossref","first-page":"00571","DOI":"10.1183\/23120541.00571-2022","article-title":"Short-acting \u03b22-agonists and exacerbations in children with asthma in England: SABINA Junior","volume":"9","author":"Morgan","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.prrv.2026.02.002_b0525","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/archdischild-2013-305147","article-title":"Respiratory viruses in exacerbations of non-cystic fibrosis bronchiectasis in children","volume":"99","author":"Kapur","year":"2014","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.prrv.2026.02.002_b0530","doi-asserted-by":"crossref","unstructured":"Chang CC, Morris PS, Chang AB. Influenza vaccine for children and adults with bronchiectasis. Cochrane Database Syst Rev 2007;2007:CD006218. https:\/\/doi.org\/10.1002\/14651858.CD006218.pub2.","DOI":"10.1002\/14651858.CD006218.pub2"},{"key":"10.1016\/j.prrv.2026.02.002_b0535","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/2051013613480770","article-title":"Influenza vaccination in children at high risk of respiratory disease","volume":"1","author":"Patria","year":"2013","journal-title":"Ther Adv Vaccines"},{"key":"10.1016\/j.prrv.2026.02.002_b0540","doi-asserted-by":"crossref","unstructured":"Chang CC, Singleton RJ, Morris PS, Chang AB. Pneumococcal vaccines for children and adults with bronchiectasis. Cochrane Database Syst Rev 2009;2009:CD006316. https:\/\/doi.org\/10.1002\/14651858.CD006316.pub3.","DOI":"10.1002\/14651858.CD006316.pub3"},{"key":"10.1016\/j.prrv.2026.02.002_b0545","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1016\/j.vaccine.2008.05.037","article-title":"Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease","volume":"26","author":"Furumoto","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.prrv.2026.02.002_b0550","first-page":"2768","volume":"14","author":"O\u2019Grady","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.prrv.2026.02.002_b0555","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/17476348.2024.2369716","article-title":"The impact of smoking on bronchiectasis and its comorbidities","volume":"18","author":"de la Rosa-Carrillo","year":"2024","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0560","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1164\/rccm.201604-0804OC","article-title":"Electronic cigarette use and respiratory symptoms in adolescents","volume":"195","author":"McConnell","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0565","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/ppul.25062","article-title":"Bronchiectasis associated with electronic cigarette use: a case series","volume":"55","author":"Mull","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.prrv.2026.02.002_b0570","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jama.2015.8950","article-title":"Association of electronic cigarette use with initiation of combustible tobacco product smoking in early adolescence","volume":"314","author":"Leventhal","year":"2015","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.prrv.2026.02.002_b0575","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1440-1754.2003.00101.x","article-title":"Paediatric bronchiectasis in the twenty-first century: experience of a tertiary children\u2019s hospital in New Zealand","volume":"39","author":"Edwards","year":"2003","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.prrv.2026.02.002_b0580","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1513\/AnnalsATS.201406-257OC","article-title":"Bronchiectasis in children from Qikiqtani (Baffin) Region, Nunavut","volume":"12","author":"Das","year":"2015","journal-title":"Canada Ann Am Thorac Soc"},{"key":"10.1016\/j.prrv.2026.02.002_b0585","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/17476348.2017.1338949","article-title":"The association between environmental tobacco smoke exposure and childhood respiratory disease: a review","volume":"11","author":"Vanker","year":"2017","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0590","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1745-9974-2-11","article-title":"Chronic productive cough in school children: prevalence and associations with asthma and environmental tobacco smoke exposure","volume":"2","author":"Carter","year":"2006","journal-title":"Cough"},{"key":"10.1016\/j.prrv.2026.02.002_b0595","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/thoraxjnl-2021-217041","article-title":"Secondhand nicotine vaping at home and respiratory symptoms in young adults","volume":"77","author":"Islam","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.prrv.2026.02.002_b0600","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1289\/ehp.8742","article-title":"Reduction in asthma morbidity in children as a result of home remediation aimed at moisture sources","volume":"114","author":"Kercsmar","year":"2006","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.prrv.2026.02.002_b0605","doi-asserted-by":"crossref","first-page":"e129","DOI":"10.1016\/j.jcf.2021.08.015","article-title":"Indoor air pollution exposure is associated with greater morbidity in cystic fibrosis","volume":"21","author":"Carson","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.prrv.2026.02.002_b0610","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02557-2017","article-title":"The impact of acute air pollution fluctuations on bronchiectasis pulmonary exacerbation: a case-crossover analysis","volume":"52","author":"Goeminne","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.prrv.2026.02.002_b0615","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1164\/rccm.200306-779OC","article-title":"Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis","volume":"169","author":"Goss","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.prrv.2026.02.002_b0620","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1164\/rccm.202402-0411OC","article-title":"Radiographic Outcomes in Pediatric Bronchiectasis and Factors Associated with Reversibility","volume":"210","author":"Mills","year":"2024","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Paediatric Respiratory Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054226000187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526054226000187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T21:24:09Z","timestamp":1771536249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526054226000187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":124,"alternative-id":["S1526054226000187"],"URL":"https:\/\/doi.org\/10.1016\/j.prrv.2026.02.002","relation":{},"ISSN":["1526-0542"],"issn-type":[{"value":"1526-0542","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatable traits in children with bronchiectasis","name":"articletitle","label":"Article Title"},{"value":"Paediatric Respiratory Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prrv.2026.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}